FDA on Hot Seat as Congress Probes Compounding Imbroglio

FDA Commissioner Margaret A. Hamburg was questioned for more than four hours Wednesday about the agency's failure to communicate proactively with the Massachusetts Department of Public Health or to provide adequate oversight of the New England Compounding Center, which has been implicated in 32 deaths.